04 Saab 93 Arc Turbo Manual Warranty No Accidents Heated Seats Ivory Leather Nj on 2040-cars

Auto blog

NEVS, Dongfeng ready to make more green cars

National Electric Vehicle Sweden AB (NEVS), the owner of the sorta-still-there Saab automobile brand, has reached a deal with Dongfeng Motor Corp. in which the China-based automaker will help NEVS develop greener vehicles. NEVS and Dongfeng have been working together since July, though the agreement was officially announced Monday. The companies say the agreement relates to so-called "new-energy" vehicles, though neither details of what those new energy vehicles will be nor financial terms were disclosed. But there's long been talk about Saab working on electrified vehicles, so this appears to be a move in the right direction. NEVS has picked a large company as its development partner. As part of the agreement, Dongfeng will speed up the development of advanced powertrains at its plant in Tiajin, China. In return, NEVS will help Dongfeng get distribution in both North America and Europe while helping the Chinese automaker sort through the matrix of developing vehicles that meet regulatory standards in those two regions, which is no easy task. Dongfeng made more than 3.8 million vehicles last year, and has done business with Peugeot, Citroen, Renault, Nissan, Honda, and Kia. Last we reported, NEVS was in the process of reorganization this past winter, and it's unclear how that will impact the relationship with Dongfeng. Also unclear is the status of the Saab brand name. The Saab AB aerospace company is no longer affiliated with the automaker and disputes NEVS using its name, but the NEVS website still highlights the Saab automotive brand. NEVS bought Saab out of bankruptcy in 2012. The latest NEVS press release is available below. Related Video: Nevs and Dongfeng tie-up for long-term strategic cooperation National Electric Vehicle Sweden AB (Nevs) and Dongfeng Motor Corporation (Dongfeng) signed a strategic cooperation agreement on August 17, 2015 to achieve global industrial synergies. Since July 2015, Nevs has started working with Dongfeng on complete vehicle development projects to enhance Dongfeng's technical strength and improve Nevs' own development capability. Now both parties have agreed to expand their cooperation from technical development to further business areas such as global purchasing and distribution network. Dongfeng has formed several strategic long term partnerships with other international major car manufacturers including AB Volvo and as a 14 percent shareholder of PSA.

Saab 9-3 production to start in China in 2013 [UPDATE]

We knew that National Electric Vehicle Sweden planned to restart production of the last-gen Saab 9-3 at some point in the future, we just didn't know exactly when, or exactly where. As it turns out, the answers to those questions are soon, and China.
Though NEVS had initially said it will build vehicles in Sweden before shipping them to China, the latest report from Autocar suggests that the cars will instead be built right in Quingdao starting later in 2013. That's right, this calendar year. Also on the docket is a followup electric version of the 9-3, which is slated to come to market in 2014 in an effort to satiate China's wish that there be half a million EVs silently filling its streets within the next two years.
NEVS wants to be part of the EV solution, but it's not going to be easy. Naturally, if these cars are to be built in China, a factory has to be located or built, tooling needs to be in place, workers need to be hired and trained and a lengthy trail of paperwork has to be signed off by the government before even the well-known gasoline-powered 9-3 can be a reality, let along the unknown quantity that is the 9-3 ePower.

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.